Flowbone

Lausanne, Switzerland Founded: 2014 • Age: 12 yrs
Injectable biomaterial is developed for osteoporosis bone treatment.
Request Access

About Flowbone

Flowbone is a company based in Lausanne (Switzerland) founded in 2014 by Ulrike Kettenberger and Dominique Pioletti.. Flowbone has raised $2.14 million across 5 funding rounds from investors including EIT Health, FIT and Venture Kick. Flowbone operates in a competitive market with competitors including Rani Therapeutics, Tarsa Therapeutics, Zosano Pharma, Radius Recycling and Novo Biosciences, among others.

  • Headquarter Lausanne, Switzerland
  • Founders Ulrike Kettenberger, Dominique Pioletti
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.14 M (USD)

    in 5 rounds

  • Latest Funding Round
    $2.14 M (USD), Seed

    Oct 06, 2022

  • Investors
    EIT Health

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Flowbone

Flowbone has successfully raised a total of $2.14M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $2.14 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Seed — $2.1M
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2022 Amount Seed - Flowbone Valuation

investors

Sep, 2021 Amount Debt – Conventional - Flowbone Valuation

investors

FIT
Nov, 2020 Amount Grant - Flowbone Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Flowbone

Flowbone has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include EIT Health, FIT and Venture Kick. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Grants and loans are provided by FIT for innovative startups.
Founded Year Domain Location
Healthcare startups are accelerated and incubated through specialized programs.
Founded Year Domain Location
University backed startup accelerator
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Flowbone

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Flowbone

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Flowbone Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Flowbone

Flowbone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rani Therapeutics, Tarsa Therapeutics, Zosano Pharma, Radius Recycling and Novo Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Technology for oral delivery of large drug molecules is developed.
domain founded_year HQ Location
Oral treatments for postmenopausal osteoporosis are developed.
domain founded_year HQ Location
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
domain founded_year HQ Location
Steel is manufactured and scrap metal is recycled.
domain founded_year HQ Location
Small molecule therapies that reactivate and stimulate innate healing abilities in humans and animals
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Flowbone

Frequently Asked Questions about Flowbone

When was Flowbone founded?

Flowbone was founded in 2014 and raised its 1st funding round 5 years after it was founded.

Where is Flowbone located?

Flowbone is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.

Is Flowbone a funded company?

Flowbone is a funded company, having raised a total of $2.14M across 5 funding rounds to date.

What does Flowbone do?

Flowbone was founded in 2014 in Lausanne, Switzerland, within the medical device sector. An injectable biomaterial named Flowbone is produced by the company, targeting osteoporosis through minimally invasive procedures. The material is delivered via a thin cannula into affected bone regions, where natural mineralization is stimulated to form new bone tissue. Operations focus on research and development of this technology for clinical applications.

Who are the top competitors of Flowbone?

Flowbone's top competitors include Rani Therapeutics, Radius Recycling and Tarsa Therapeutics.

Who are Flowbone's investors?

Flowbone has 3 investors. Key investors include EIT Health, FIT, and Venture Kick.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available